<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36936268</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2754-0413</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>BMJ medicine</Title><ISOAbbreviation>BMJ Med</ISOAbbreviation></Journal><ArticleTitle>Effect of covid-19 vaccination on long covid: systematic review.</ArticleTitle><Pagination><StartPage>e000385</StartPage><MedlinePgn>e000385</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e000385</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjmed-2022-000385</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To determine the effect of covid-19 vaccination, given before and after acute infection with the SARS-CoV-2 virus, or after a diagnosis of long covid, on the rates and symptoms of long covid.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">Systematic review.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="UNASSIGNED">PubMed, Embase, and Cochrane covid-19 trials, and Europe PubMed Central (Europe PMC) for preprints, from 1 January 2020 to 3 August 2022.</AbstractText><AbstractText Label="ELIGIBILITY CRITERIA FOR SELECTING STUDIES" NlmCategory="UNASSIGNED">Trials, cohort studies, and case-control studies reporting on patients with long covid and symptoms of long covid, with vaccination before and after infection with the SARS-CoV-2 virus, or after a diagnosis of long covid. Risk of bias was assessed with the ROBINS-I tool.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">1645 articles were screened but no randomised controlled trials were found. 16 observational studies from five countries (USA, UK, France, Italy, and the Netherlands) were identified that reported on 614&#x2009;392 patients. The most common symptoms of long covid that were studied were fatigue, cough, loss of sense of smell, shortness of breath, loss of taste, headache, muscle ache, difficulty sleeping, difficulty concentrating, worry or anxiety, and memory loss or confusion. 12 studies reported data on vaccination before infection with the SARS-CoV-2 virus, and 10 showed a significant reduction in the incidence of long covid: the odds ratio of developing long covid with one dose of vaccine ranged from 0.22 to 1.03; with two doses, odds ratios were 0.25-1; with three doses, 0.16; and with any dose, 0.48-1.01. Five studies reported on vaccination after infection, with odds ratios of 0.38-0.91. The high heterogeneity between studies precluded any meaningful meta-analysis. The studies failed to adjust for potential confounders, such as other protective behaviours and missing data, thus increasing the risk of bias and decreasing the certainty of evidence to low.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Current studies suggest that covid-19 vaccines might have protective and therapeutic effects on long covid. More robust comparative observational studies and trials are needed, however, to clearly determine the effectiveness of vaccines in preventing and treating long covid.</AbstractText><AbstractText Label="PROTOCOL REGISTRATION" NlmCategory="UNASSIGNED">Open Science Framework https://osf.io/e8jdy.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Byambasuren</LastName><ForeName>Oyungerel</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-8641-1286</Identifier><AffiliationInfo><Affiliation>Bond University, Robina, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stehlik</LastName><ForeName>Paulina</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-5397-228X</Identifier><AffiliationInfo><Affiliation>Bond University, Robina, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Justin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0133-1613</Identifier><AffiliationInfo><Affiliation>Bond University, Robina, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alcorn</LastName><ForeName>Kylie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Gold Coast University Hospital, Southport, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glasziou</LastName><ForeName>Paul</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-7564-073X</Identifier><AffiliationInfo><Affiliation>Bond University, Robina, Queensland, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Med</MedlineTA><NlmUniqueID>9918487584306676</NlmUniqueID><ISSNLinking>2754-0413</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid-19</Keyword></KeywordList><CoiStatement>Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>20</Day><Hour>3</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36936268</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pii">bmjmed-2022-000385</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. . Characterising long covid: a living systematic review. BMJ Glob Health 2021;6:e005427. 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. Do vaccines protect against long covid? What the data say. Nature 2021;599:546&#x2013;8. 10.1038/d41586-021-03495-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-03495-2</ArticleId><ArticleId IdType="pubmed">34815580</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, et al. . Global prevalence of post-coronavirus disease 2019 (covid-19) condition or long covid: a meta-analysis and systematic review. J Infect Dis 2022;226:1593&#x2013;607. 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. . Persistent covid-19 symptoms in a community study of 606,434 people in England. Nat Commun 2022;13:1957. 10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo SM, Liu TC, Motwani Y, et al. . Factors associated with post-acute sequelae of SARS-CoV-2 (PASC) after diagnosis of symptomatic covid-19 in the inpatient and outpatient setting in a diverse cohort. J Gen Intern Med 2022;37:1988&#x2013;95. 10.1007/s11606-022-07523-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07523-3</ArticleId><ArticleId IdType="pmc">PMC8989256</ArticleId><ArticleId IdType="pubmed">35391623</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, et al. . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022;22:e102&#x2013;7. 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, et al. . A clinical case definition of post-covid-19 condition by a Delphi consensus. Lancet Infect Dis 2022;22:e102&#x2013;7. 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. . More than 50 long-term effects of covid-19: a systematic review and meta-analysis. Sci Rep 2021;11:16144. 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes LD, Ingram J, Sculthorpe NF. More than 100 persistent symptoms of SARS-CoV-2 (long covid): a scoping review. Front Med 2021;8:750378. 10.3389/fmed.2021.750378</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.750378</ArticleId><ArticleId IdType="pmc">PMC8591053</ArticleId><ArticleId IdType="pubmed">34790680</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, et al. . Long-term sequelae of covid-19: a systematic review and meta-analysis of one-year follow-up studies on post-covid symptoms. Pathogens 2022;11:269. 10.3390/pathogens11020269</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. Do vaccines protect from long covid? Lancet Respir Med 2022;10:e30&#x2013;e. 10.1016/S2213-2600(22)00020-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00020-0</ArticleId><ArticleId IdType="pmc">PMC8776281</ArticleId><ArticleId IdType="pubmed">35065716</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P, Gorelik Y, Zayyad H, et al. . Association between vaccination status and reported incidence of post-acute covid-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021. medRxiv 2022. 10.1038/s41541-022-00526-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-022-00526-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, De Martino M, Palese A, et al. . Post-covid-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients. Clin Microbiol Infect 2022;28:1140&#x2013;8. 10.1016/j.cmi.2022.03.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.03.016</ArticleId><ArticleId IdType="pmc">PMC8940723</ArticleId><ArticleId IdType="pubmed">35339673</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark J, Glasziou P, Del Mar C, et al. . A full systematic review was completed in 2 weeks using automation tools: a case study. J Clin Epidemiol 2020;121:81&#x2013;90. 10.1016/j.jclinepi.2020.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2020.01.008</ArticleId><ArticleId IdType="pubmed">32004673</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264&#x2013;9. 10.7326/0003-4819-151-4-200908180-00135</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-151-4-200908180-00135</ArticleId><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark JM, Sanders S, Carter M, et al. . Improving the translation of search strategies using the Polyglot search translator: a randomized controlled trial. J Med Libr Assoc 2020;108:195&#x2013;207. 10.5195/jmla.2020.834</Citation><ArticleIdList><ArticleId IdType="doi">10.5195/jmla.2020.834</ArticleId><ArticleId IdType="pmc">PMC7069833</ArticleId><ArticleId IdType="pubmed">32256231</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, et al. . ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355:i4919. 10.1136/bmj.i4919</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Schunemann JH, Vist EG, Higgins PJ, et al. . Chapter 15: Interpreting results and drawing conclusions. In: Cochrane Handbook for Systematic Reviews of Interventions, version 63, 2022.</Citation></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long covid after breakthrough SARS-CoV-2 infection. Nat Med 2022;28:1461&#x2013;7. 10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. . Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the covid symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis 2022;22:43&#x2013;55. 10.1016/S1473-3099(21)00460-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bosworth ML, King S, et al. . Risk of long covid in people infected with SARS-CoV-2 after two doses of a covid-19 vaccine: community-based matched cohort study. Open Forum Infect Dis 2022. 10.1093/ofid/ofac464</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac464</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E, Levi R, Sarti R, et al. . Association between BNT162b2 vaccination and long covid after infections not requiring hospitalization in health care workers. JAMA 2022;328:676. 10.1001/jama.2022.11691</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou GN, Baraff A, Fox A, et al. . Rates and factors associated with documentation of diagnostic codes for long covid in the National Veterans Affairs health care system. JAMA Netw Open 2022;5:e2224359&#x2013;undefined. 10.1001/jamanetworkopen.2022.24359</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.24359</ArticleId><ArticleId IdType="pmc">PMC9338411</ArticleId><ArticleId IdType="pubmed">35904783</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr NM, Plumb ID, Harland KK, et al. . Presence of symptoms 6 weeks after covid-19 among vaccinated and unvaccinated U.S. healthcare personnel. medRxiv 2022. 10.1101/2022.02.16.22271092</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.16.22271092</ArticleId><ArticleId IdType="pmc">PMC9895915</ArticleId><ArticleId IdType="pubmed">36731936</ArticleId></ArticleIdList></Reference><Reference><Citation>Pell J, Hastie C, Lowe D. Long-covid COVID in Scotland study: a nationwide, population cohort study. Research Square 2022. 10.21203/rs.3.rs-1656915/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1656915/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Tannous J, Pan AP, Potter T, et al. . Real world evidence of effectiveness of covid-19 vaccines and anti SARS-CoV-2 monoclonal antibodies against post-acute sequelae of SARS-CoV-2 infection. medRxiv 2022. 10.1101/2022.06.30.22277105</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.30.22277105</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun 2022;103:154-162. 10.1016/j.bbi.2022.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Maaden T, Mutubuki EN, de Bruijn S, et al. . Prevalence and severity of symptoms 3 months after infection with SARS-CoV-2 compared to test-negative and population controls in the Netherlands. J Infect Dis 2022. doi:10.1093/infdis/jiac474. [Epub ahead of print: 07 Dec 2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac474</ArticleId><ArticleId IdType="pubmed">36477364</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisis SN, Durieux JC, Mouchati C, et al. . The protective effect of coronavirus disease 2019 (COVID-19) vaccination on postacute sequelae of covid-19: a multicenter study from a large national health research network. Open Forum Infect Dis 2022;9:ofac228&#x2013;undefined. 10.1093/ofid/ofac228</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac228</ArticleId><ArticleId IdType="pmc">PMC9129153</ArticleId><ArticleId IdType="pubmed">35818362</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, et al. . Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ 2022;377:e069676. 10.1136/bmj-2021-069676</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon MA, Luginbuhl RD, Parker R. Reduced incidence of long-covid symptoms related to administration of covid-19 vaccines both before COVID-19 diagnosis and up to 12 weeks after. medRxiv 2021. 10.1101/2021.11.17.21263608</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.17.21263608</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V-T, Perrodeau E, Saldanha J, et al. . Efficacy of covid-19 vaccination on the symptoms of patients with long covid: a target trial emulation using data from the compare e-Cohort in France. SSRN Journal 2021. 10.2139/ssrn.3932953</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3932953</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisnivesky JP, Govindarajulu U, Bagiella E, et al. . Association of vaccination with the persistence of post-covid symptoms. J Gen Intern Med 2022;37:1748&#x2013;53. 10.1007/s11606-022-07465-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07465-w</ArticleId><ArticleId IdType="pmc">PMC8906626</ArticleId><ArticleId IdType="pubmed">35266128</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E, Han AX, Boyd A, et al. . The effect of SARS-CoV-2 vaccination on post-acute sequelae of covid-19 (PASC): a prospective cohort study. Vaccine 2022;40:4424&#x2013;31. 10.1016/j.vaccine.2022.05.090</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.05.090</ArticleId><ArticleId IdType="pmc">PMC9170535</ArticleId><ArticleId IdType="pubmed">35725782</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler CX, Wyller VBB, Moss-Morris R, et al. . Long covid and post-infective fatigue syndrome: a review. Open Forum Infect Dis 2021;8:ofab440. 10.1093/ofid/ofab440</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab440</ArticleId><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman JK, Greenland S. Modern epidemiology. Chapter 4. Lippincott-Raven: Measures of Effect and Measures of Association, 1998.</Citation></Reference><Reference><Citation>Xie Y, Bowe B, Al-Aly Z. Burdens of post-acute sequelae of covid-19 by severity of acute infection, demographics and health status. Nat Commun 2021;12:6571. 10.1038/s41467-021-26513-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26513-3</ArticleId><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, et al. . Impact of covid-19 vaccination on the risk of developing long-covid and on existing long-covid symptoms: a systematic review. EClinicalMedicine 2022;53:101624. 10.1016/j.eclinm.2022.101624</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumtaz A, Sheikh AAE, Khan AM, et al. . Covid-19 vaccine and long covid: a scoping review. Life 2022;12:1066. 10.3390/life12071066</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12071066</ArticleId><ArticleId IdType="pmc">PMC9324565</ArticleId><ArticleId IdType="pubmed">35888154</ArticleId></ArticleIdList></Reference><Reference><Citation>Ontario Agency for Health Protection and Promotion (Public Health Ontario) . Impact of vaccination on post-acute covid-19 syndrome (PACS) &#x2013; what we know so far. Toronto, ON: Queen&#x2019;s Printer for Ontario, 2022.</Citation></Reference><Reference><Citation>
UK Health Security Agency . The effectiveness of vaccination against long covid: a rapid evidence briefing; 2022. https://ukhsa.koha-ptfs.co.uk/cgi-bin/koha/opac-retrieve-file.pl?id=fe4f10cd3cd509fe045ad4f72ae0dfff
</Citation></Reference><Reference><Citation>
Office for National Statistics . Prevalence of ongoing symptoms following coronavirus (covid-19) infection in the UK; 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1june2022 [Accessed 01 Jun 2022].</Citation></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, et al. . Risk of long covid associated with delta versus omicron variants of SARS-CoV-2. Lancet 2022;399:2263&#x2013;4. 10.1016/S0140-6736(22)00941-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M, Pijnenburg L, Chatelus E, et al. . Effect of SARS-CoV-2 vaccination on symptoms from post-acute sequelae of COVID-19: results from the nationwide VAXILONG study. Vaccines 2022;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8781023</ArticleId><ArticleId IdType="pubmed">35062706</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Valentini P, Macchi M, et al. . Caregivers' attitudes toward covid-19 vaccination in children and adolescents with a history of SARS-CoV-2 infection. Front Pediatr 2022;10:867968. 10.3389/fped.2022.867968</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.867968</ArticleId><ArticleId IdType="pmc">PMC9021633</ArticleId><ArticleId IdType="pubmed">35463893</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>